drugset / Trial / NCT00002227

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002227

Phase 2 Completed 60 enrolled Dupont Merck
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give efavirenz plus stavudine plus lamivudine to patients who have never taken anti-HIV drugs.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified
Subject Lamivudine Other / unclassified
Subject Stavudine Other / unclassified